FMS Earnings & Financial Statements
Fresenius Medical Care AG & Co. KGaA
$22.13
+$0.59(+2.74%)
54
Overall
100
Value
18
Tech
44
Quality
Market Cap
$12.03B
Volume
1.46M
52W Range
$20.02 - $27.54
Target Price
$22.06
FMS earnings and financial statements: Fresenius Medical Care AG & Co. KGaA's income statement, balance sheet and cash flow statement, annual and quarterly.
FMS Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $19.63B | $19.34B | $19.45B | $19.40B | $17.62B |
| Cost of revenue | $14.60B | $14.58B | $14.53B | $14.50B | $12.85B |
| Operating income | $1.12B | $497.40M | $998.74M | $1.97B | $2.73B |
| EBITDA | $3.40B | $3.21B | $2.18B | $3.42B | $3.55B |
| Net income | $978.37M | $537.91M | -$531.50M | $673.40M | $969.31M |
| EPS (diluted) | - | $0.92 | $0.85 | $1.15 | $1.66 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $31.00B | $33.57B | $33.93B | $34.48B | $34.37B |
| Total liabilities | $16.72B | $17.80B | $19.10B | $20.45B | $20.39B |
| Shareholders’ equity | $13.31B | $14.58B | $13.62B | $13.70B | $12.70B |
| Cash and equivalents | $1.60B | $1.18B | $1.40B | $773.72M | $925.13M |
| Long-term debt | $5.69B | $6.26B | $6.96B | $7.17B | $10.73B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $2.68B | $2.39B | $2.63B | $2.17B | $2.49B |
| Capital expenditure | - | - | - | $36.20M | -$854.36M |
| Free cash flow | $1.77B | $1.69B | $1.96B | $2.20B | $2.51B |
| Dividends paid | $422.51M | $349.16M | $328.62M | $395.56M | $392.45M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FMS | $22.13 | +2.7% | 1.46M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Fresenius Medical Care AG & Co. KGaA Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW